Drawing for TOPOTARGET

USPTO serial 79009747

TOPOTARGET

Reviewed by CopyMark Law Group

Reg. 3247679Status 404
Filing date
Status date
Registration date
May 29, 2007
Examiner
TANNER, MICHAEL R
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TOPOTARGET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

ROSEMARY TARLTON

ROSEMARY TARLTON MORRISON & FOERSTER LLP425 MARKET STSAN FRANCISCO, CA 94105-2406UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry and scienceSECTION 71 - CANCELLED—
005Pharmaceuticals, namely, pharmaceutical preparations for the treatment of or the diagnosis of multiple sclerosis, amyotrophic lateral sclerosis (ALS), Huntingdon's disease, spinal muscular atrophy, adenomatous polyposis coli, reproductive disorders, endocrinology disease, urological disorders, respiratory disorders, asthma, allergies, cancers, infectious organisms, bacterial infections, drug resistance, bacterial drug resistance, metabolic disorders, inflammation, cardiovascular diseases, viral infections, gene therapy treatments, viral latency, genetic disorders, sickle cell anemia, restenosis, thallasemia, bacterial infections, diabetes, central nervous system disorders and diseases, depression, schizophrenia, obesity, parasitic infections, fungal infections, skin diseases, namely, skin cancer, basal cell carcinoma, squamous cell carcinoma, keratocanthoma, Bowen disease, cutaneous T-cell lymphoma, dermatitis, actinic keratosis, keloids, psoriasis, ichthyosis, acne, skin inflammation, sunburn, prophylaxis and treatment of radiation damage, arthritis, osteoporosis, circulatory disease, degenerative disorders, autoimmune disease, gastrointestinal disorders and diseases, musculoskeletal disorders and diseases, hematologic disorders and diseases, renal disease, connective tissue and joint disease, eye disease, namely, hordeolum, chalazion, blepharitis, lagophthalmos, blepharochalasis, parasitic infestation of eye, dacryoadenitis, conjunctivitis, pterygium, scleritis, keratitis, iritis, uveitis, retinopathy, macular degeneration, macular edema, glaucoma and keratomycosis; chemical preparations and reagents for medical useSECTION 71 - CANCELLED—
010Medical and surgical apparatus and instruments, namely, syringes, catheters, infusion bags and structural parts therefor; medical and surgical apparatus and instruments for use in general surgery and structural parts thereforSECTION 71 - CANCELLED—
042Computer services, namely, providing search engines for obtaining data and information relating to drug discovery, drug development, medical research, veterinary research and scientific research; scientific services, namely, scientific research services, scientific research and development, scientific investigations for medical purposes; drug discovery and drug development services, namely, pharmaceutical drug development services, pharmaceutical research and development, pharmaceutical product evaluation, conducting early evaluations in the field of new pharmaceuticals, conducting pharmaceutical clinical trials for othersSECTION 71 - CANCELLED—
044Medical and veterinary servicesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 4, 2015INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jul 10, 2015DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Jul 10, 2015DETHDEATH OF INTERNATIONAL REGISTRATION—
Feb 17, 2015INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Feb 17, 2015INPCINVALIDATION PROCESSED—
Sep 3, 2014INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 3, 2014C71TCANCELLED SECTION 71—
Aug 14, 2008FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 30, 2007FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 30, 2007FIMPFINAL DISPOSITION PROCESSED—
Oct 22, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 29, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 28, 2006ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Nov 9, 2006OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 12, 2006OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 4, 2006ATRVATTORNEY REVIEW COMPLETED—
Sep 28, 2006OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 28, 2006OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 8, 2006AMPBAMENDMENT/PETITION AFTER APPROVAL FOR PUB ENTERED—
Jul 28, 2006MAILPAPER RECEIVED—
Jun 14, 2006ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
May 16, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 26, 2006NPUBNOTICE OF PUBLICATION—
Mar 22, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 10, 2006ALIEASSIGNED TO LIE—
Mar 9, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 9, 2006CNEAEXAMINERS AMENDMENT MAILED—
Mar 8, 2006XAECEXAMINER'S AMENDMENT ENTERED—
Mar 8, 2006CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 17, 2006ACECAMENDMENT FROM APPLICANT ENTERED—
Jan 30, 2006MAILPAPER RECEIVED—
Jan 27, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 18, 2005RFNPREFUSAL PROCESSED BY IB—
Jul 27, 2005RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 22, 2005RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 21, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 19, 2005DOCKASSIGNED TO EXAMINER—
Apr 29, 2005NWAPNEW APPLICATION ENTERED—
Apr 28, 2005REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance